The capacity of pharmaceutical pollution to alter behaviour in wildlife is of increasing concern to the scientific community. A major pathway of these contaminants into the environment is the treatment of livestock with hormonal growth promotants (HGPs), highly potent veterinary pharmaceuticals that can enter aquatic ecosystems via effluent runoff. Hormonal growth promotants are designed to have biological effects at low doses, often act on physiological pathways that are evolutionarily conserved across taxa, and have repeatedly been detected in ecosystems worldwide. However, despite being shown to cause altered development, reproduction and morphology in various non-target species, relatively little is known about the potential of HGPs to alter ecologically important behaviours, especially across multiple contexts. Here, we investigated the effects of short-term (21-day) exposure to field-detected levels (average measured concentration: 16 ng/L) of 17β-trenbolone—a potent growth-promoting veterinary pharmaceutical repeatedly detected in freshwater systems—on a suite of ecologically important behaviours in female eastern mosquitofish (Gambusia holbrooki). We found that fish exposed to 17β-trenbolone were more active and exploratory in a novel environment (i.e. maze arena), while boldness was not significantly affected. Further, when tested for sociability, exposed fish were again more active and exploratory, and spent less time associating with a shoal of stimulus (i.e. unexposed) conspecific females. Lastly, when assayed for foraging behaviour, exposed fish spent a greater total amount of time within a foraging zone containing an array of prey items (chironomid larvae) than did unexposed fish, entered this zone more frequently, and were more likely to feed. Further, a significant effect of exposure was detected on the total number of prey items consumed, although treatment-induced increases in foraging behaviour were dependent on female size. Taken together, these findings highlight the potential for sub-lethal levels of veterinary pharmaceuticals detected in the environment to alter sensitive behavioural processes in wildlife across multiple contexts, with possible ecological and evolutionary implications for exposed populations.